AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 22210231 — intervention group
Group type: EXPERIMENTAL
Intervention: TIVA group (propofol-remifentanil-N2O)
Number of subjects: 46
Study 22210231 — intervention group
Group type: COMPARATOR
Intervention: Inhalation group (sevoflurane-N2O)
Number of subjects: 46
Study 20563735 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical tramadol (2 mg/kg diluted in 10 ml saline)
Number of subjects: 40
Study 20563735 — intervention group
Group type: COMPARATOR
Intervention: Control group (10 ml saline)
Number of subjects: 40
Study 17049322 — intervention group
Group type: COMPARATOR
Intervention: Propofol plus placebo (group A)
Number of subjects: 270
Study 17049322 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol plus midazolam (group B)
Number of subjects: 270
Study 11339443 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid (0.5-5 mg daily)
Number of subjects: 1114
Study 11339443 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin B12 (mean 0.5 mg daily)
Number of subjects: 1114
Study 11339443 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin B6 (mean 16.5 mg daily)
Number of subjects: 1114
Study 9347206 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral triphasic contraceptive steroids (ethinyl estradiol and levonorgestrel)
Number of subjects: 112
Study 8137343 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic low dose etoposide administration (21 days)
Number of subjects: 0
Study 8137343 — intervention group
Group type: COMPARATOR
Intervention: Frequent weekly or twice weekly administration of larger intravenous doses
Number of subjects: 0
Study 8137343 — intervention group
Group type: EXPERIMENTAL
Intervention: Measurement of active intracellular drug concentrations
Number of subjects: 0
Study 3533811 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 micrograms L‐triiodothyronine
Number of subjects: 20
Study 3533811 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 30572991 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A (1,500-2,000 IU daily)
Number of subjects: 46
Study 30572991 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-intervention (Insulin treatment only)
Number of subjects: 46
Study 30572991 — intervention group
Group type: COMPARATOR
Intervention: Control group (25 healthy children)
Number of subjects: 46
Study 26954945 — intervention group
Group type: EXPERIMENTAL
Intervention: Fractionated coconut oil 1.0 mL infused in the uterus on Day 10 (Group 1; n = 5)
Number of subjects: 18
Study 26954945 — intervention group
Group type: EXPERIMENTAL
Intervention: Fractionated coconut oil 0.5 mL infused in the uterus on Day 10 (Group 2; n = 5)
Number of subjects: 18
Study 26954945 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 5)
Number of subjects: 18
Study 24997853 — intervention group
Group type: COMPARATOR
Intervention: 20mg E4 per day for 14 days
Number of subjects: 30
Study 23252201 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 g of cefoxitin
Number of subjects: 84
Study 23252201 — intervention group
Group type: COMPARATOR
Intervention: 0.1 ml of vitamin B complex intravenously
Number of subjects: 84
Study 19927027 — intervention group
Group type: EXPERIMENTAL
Intervention: 35% protein (approximately 2.3 g x kg(‐1))
Number of subjects: 20
Study 19927027 — intervention group
Group type: COMPARATOR
Intervention: 15% protein (approximately 1.0 g x kg(‐1))
Number of subjects: 20
Study 18700714 — intervention group
Group type: EXPERIMENTAL
Intervention: Abhay M vaccine
Number of subjects: 600
Study 18700714 — intervention group
Group type: COMPARATOR
Intervention: M-Vac vaccine
Number of subjects: 600
Study 18700714 — intervention group
Group type: EXPERIMENTAL
Intervention: Both vaccines
Number of subjects: 600
Study 15616965 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial (tc) stimulation
Number of subjects: 42
Study 15616965 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumbosacral (ls) stimulation
Number of subjects: 42
Study 15616965 — intervention group
Group type: EXPERIMENTAL
Intervention: Ratio of tx/ls latencies
Number of subjects: 42
Study 15616965 — intervention group
Group type: EXPERIMENTAL
Intervention: Tc evoked mechanical pressure responses
Number of subjects: 42
Study 15616965 — intervention group
Group type: EXPERIMENTAL
Intervention: EPC and MEP diagnostic tool
Number of subjects: 42
Study 12879826 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition training programme delivered by a dietitian to primary care teams.
Number of subjects: 251
Study 12879826 — intervention group
Group type: COMPARATOR
Intervention: Control group (no nutrition training programme).
Number of subjects: 251
Study 10392981 — intervention group
Group type: EXPERIMENTAL
Intervention: 81 mg acetylsalicylic acid daily
Number of subjects: 2849
Study 10392981 — intervention group
Group type: EXPERIMENTAL
Intervention: 325 mg acetylsalicylic acid daily
Number of subjects: 2849
Study 10392981 — intervention group
Group type: COMPARATOR
Intervention: 650 mg acetylsalicylic acid daily
Number of subjects: 2849
Study 10392981 — intervention group
Group type: COMPARATOR
Intervention: 1300 mg acetylsalicylic acid daily
Number of subjects: 2849
Study 10392981 — intervention group
Group type: EXPERIMENTAL
Intervention: Efficacy analysis excluding patients taking 650 mg or more acetylsalicylic acid
Number of subjects: 2849
Study 8844276 — intervention group
Group type: EXPERIMENTAL
Intervention: MACTres (increased resistance, constant frequency at 100 rpm)
Number of subjects: 10
Study 8844276 — intervention group
Group type: EXPERIMENTAL
Intervention: MACTfreq (increased frequency, constant resistance at 0.077 x body weight)
Number of subjects: 10
Study 8844276 — intervention group
Group type: COMPARATOR
Intervention: MART (maximal anaerobic running test)
Number of subjects: 10
Study 8844276 — intervention group
Group type: EXPERIMENTAL
Intervention: MACTres
Number of subjects: 10
Study 8844276 — intervention group
Group type: EXPERIMENTAL
Intervention: MACTfreq
Number of subjects: 10
Study 8844276 — intervention group
Group type: COMPARATOR
Intervention: MART
Number of subjects: 10
Study 2066454 — intervention group
Group type: EXPERIMENTAL
Intervention: Adinazolam (60-90 mg/day)
Number of subjects: 66
Study 2066454 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline (150-225 mg/day)
Number of subjects: 66
Study 2066454 — intervention group
Group type: COMPARATOR
Intervention: Diazepam (30-45 mg/day)
Number of subjects: 66
Study 31116170 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonphysician competent facilitators (NPCFs)
Number of subjects: 85
Study 31116170 — intervention group
Group type: COMPARATOR
Intervention: Attending physician faculty
Number of subjects: 85
Study 28122361 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiviral therapy
Number of subjects: 174
Study 28122361 — intervention group
Group type: COMPARATOR
Intervention: Non-antiviral therapy
Number of subjects: 174
Study 26406981 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary supplement containing cinnamon, chromium and carnosine (1.2 g/day)
Number of subjects: 62
Study 26406981 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study 23579179 — intervention group
Group type: EXPERIMENTAL
Intervention: TeenCope
Number of subjects: 320
Study 23579179 — intervention group
Group type: EXPERIMENTAL
Intervention: Managing Diabetes
Number of subjects: 320
Study 21269484 — intervention group
Group type: EXPERIMENTAL
Intervention: EPO therapy (5,000 IU subcutaneously at 48 h and 72 h after acute IS)
Number of subjects: 167
Study 21269484 — intervention group
Group type: COMPARATOR
Intervention: Placebo (group 2)
Number of subjects: 167
Study 21269484 — intervention group
Group type: EXPERIMENTAL
Intervention: EPO therapy (group 1)
Number of subjects: 167
Study 19705951 — intervention group
Group type: EXPERIMENTAL
Intervention: Mandibular cervical headgear (MCH) and fixed appliances
Number of subjects: 20
Study 19705951 — intervention group
Group type: COMPARATOR
Intervention: Control group (untreated Class III subjects)
Number of subjects: 20
Study 17989311 — intervention group
Group type: EXPERIMENTAL
Intervention: Provider surveys
Number of subjects: 303
Study 17989311 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient focus groups
Number of subjects: 303
Study 17989311 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical chart audits
Number of subjects: 303
Study 15944887 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive rehabilitation program (five sessions)
Number of subjects: 40
Study 15944887 — intervention group
Group type: COMPARATOR
Intervention: Attention placebo control condition
Number of subjects: 40
Study 11845860 — intervention group
Group type: EXPERIMENTAL
Intervention: Ministernotomy (group I, n = 40)
Number of subjects: 80
Study 11845860 — intervention group
Group type: COMPARATOR
Intervention: Conventional sternotomy (group II, n = 40)
Number of subjects: 80
Study 11845860 — intervention group
Group type: EXPERIMENTAL
Intervention: Ministernotomy (group I)
Number of subjects: 80
Study 11845860 — intervention group
Group type: COMPARATOR
Intervention: Conventional sternotomy (group II)
Number of subjects: 80
Study 10395851 — intervention group
Group type: EXPERIMENTAL
Intervention: Atovaquone 750 mg once a day
Number of subjects: 549
Study 10395851 — intervention group
Group type: EXPERIMENTAL
Intervention: Atovaquone 1500 mg once a day
Number of subjects: 549
Study 10395851 — intervention group
Group type: COMPARATOR
Intervention: Aerosolized pentamidine 300 mg once a month
Number of subjects: 549
Study 10395851 — intervention group
Group type: EXPERIMENTAL
Intervention: Atovaquone (both dosages)
Number of subjects: 549
Study 8847035 — intervention group
Group type: EXPERIMENTAL
Intervention: Octreotide 100 mcg bolus intravenously followed by 25 mcg/h intravenously for 1.4 +/- 0.6 days
Number of subjects: 84
Study 8847035 — intervention group
Group type: COMPARATOR
Intervention: Ranitidine 100 mg intravenously every 12 h
Number of subjects: 84
Study 8847035 — intervention group
Group type: EXPERIMENTAL
Intervention: Octreotide
Number of subjects: 84
Study 2289639 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes protocol with self-monitoring of blood glucose (n=56)
Number of subjects: 129
Study 2289639 — intervention group
Group type: COMPARATOR
Intervention: Conventional care (control group, n=73)
Number of subjects: 129
Study 6896575 — intervention group
Group type: EXPERIMENTAL
Intervention: Isaxonine (4 capsules of 375 mg daily)
Number of subjects: 15
Study 6896575 — intervention group
Group type: COMPARATOR
Intervention: Placebo (4 capsules filled with lactose)
Number of subjects: 15
Study 31445582 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradialytic protein supplementation with exercise
Number of subjects: 0
Study 31445582 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradialytic protein supplementation without exercise
Number of subjects: 0
Study 27606613 — intervention group
Group type: EXPERIMENTAL
Intervention: 1500 ml of oral rehydration solution (rehydration group)
Number of subjects: 46
Study 27606613 — intervention group
Group type: COMPARATOR
Intervention: None (control group)
Number of subjects: 46
Study 25963302 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg pemirolast
Number of subjects: 326
Study 25963302 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 mg pemirolast
Number of subjects: 326
Study 25963302 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg pemirolast
Number of subjects: 326
Study 25963302 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 326
Study 23369651 — intervention group
Group type: EXPERIMENTAL
Intervention: Algorithmic approach in phase II using 25-gauge needle for transduodenal FNAs and 22-gauge needle for other FNAs; 19-gauge needle for transduodenal interventions and standard 19-gauge needle for others.
Number of subjects: 1048
Study 23369651 — intervention group
Group type: EXPERIMENTAL
Intervention: Algorithmic approach in phase II.
Number of subjects: 1048
Study 21374079 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual and haptic cues presented with temporal disparity
Number of subjects: 0
Study 21374079 — intervention group
Group type: COMPARATOR
Intervention: Visual and haptic cues presented synchronously
Number of subjects: 0
Study 19692922 — intervention group
Group type: EXPERIMENTAL
Intervention: Antioxidant supplementation (vitamin C 1.5 times upper intake level, vitamin E 1.35 times upper intake level, zinc 2.0 times recommended dietary allowance) for 7 days starting on the second day of hospital admission
Number of subjects: 32
Study 19692922 — intervention group
Group type: COMPARATOR
Intervention: No supplementation (placebo)
Number of subjects: 32
Study 17984344 — intervention group
Group type: EXPERIMENTAL
Intervention: Human and bovine praziquantel treatment
Number of subjects: 5390
Study 17984344 — intervention group
Group type: COMPARATOR
Intervention: Human praziquantel treatment only
Number of subjects: 5390
Study 17984344 — intervention group
Group type: EXPERIMENTAL
Intervention: Bovine contamination index calculations
Number of subjects: 5390
Study 15119493 — intervention group
Group type: EXPERIMENTAL
Intervention: Benzodiazepine treatment program
Number of subjects: 16
Study 15119493 — intervention group
Group type: COMPARATOR
Intervention: Observation with CIWA-Ar administered every eight hours for 48 hours
Number of subjects: 16
Study 11913311 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate-containing chewing gum
Number of subjects: 0
Study 11913311 — intervention group
Group type: COMPARATOR
Intervention: Sodium bicarbonate-containing toothpaste
Number of subjects: 0
Study 9152681 — intervention group
Group type: COMPARATOR
Intervention: diet AP (western animal protein-rich diet)
Number of subjects: 12
Study 9152681 — intervention group
Group type: EXPERIMENTAL
Intervention: diet VP (soy protein-rich vegetable diet)
Number of subjects: 12
Study 8178407 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG Connaught 120 mg
Number of subjects: 78
Study 8178407 — intervention group
Group type: COMPARATOR
Intervention: Interferon A 10(7) units
Number of subjects: 78
Study 2906556 — intervention group
Group type: EXPERIMENTAL
Intervention: L-tyrosine 50, 250 and 500 mg kg-1
Number of subjects: 15
Study 2906556 — intervention group
Group type: EXPERIMENTAL
Intervention: L-tyrosine 250 and 500 mg kg-1 with idazoxan (0.1 mg kg-1 i.v.)
Number of subjects: 15
Study 2906556 — intervention group
Group type: COMPARATOR
Intervention: Idazoxan (0.1 mg kg-1 i.v.)
Number of subjects: 15
Study 2906556 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 31023832 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative plasma vitamin D (25OHD) level
Number of subjects: 92
Study 31023832 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative plasma C-reactive protein (CRP) level
Number of subjects: 92
Study 31023832 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative vs postoperative plasma 25OHD levels
Number of subjects: 92
Study 31023832 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative plasma 25OHD recovery
Number of subjects: 92
Study 31023832 — intervention group
Group type: EXPERIMENTAL
Intervention: 25OHD tertile and CRC mortality
Number of subjects: 92
Study 31023832 — intervention group
Group type: EXPERIMENTAL
Intervention: 25OHD tertile and all-cause mortality
Number of subjects: 92
Study 31023832 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma 25OHD and rs11568820 genotype interaction
Number of subjects: 92
Study 29921320 — intervention group
Group type: EXPERIMENTAL
Intervention: Navoximod (GDC-0919) administered at doses of 50-800 mg BID on a 21/28 day schedule and 600 mg on a 28/28 day schedule
Number of subjects: 22
Study 29921320 — intervention group
Group type: EXPERIMENTAL
Intervention: Navoximod (GDC-0919)
Number of subjects: 22
Study 27418458 — intervention group
Group type: EXPERIMENTAL
Intervention: Enamel matrix derivative (EMD)
Number of subjects: 26
Study 27418458 — intervention group
Group type: COMPARATOR
Intervention: No EMD (control)
Number of subjects: 26
Study 27418458 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (EMD and control)
Number of subjects: 26
Study 25284751 — intervention group
Group type: EXPERIMENTAL
Intervention: Korean red ginseng (KRG) 500 mg, six capsules twice daily for 8 weeks
Number of subjects: 80
Study 25284751 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 24321164 — intervention group
Group type: EXPERIMENTAL
Intervention: Amantadine 200mg
Number of subjects: 60
Study 24321164 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetyl-L-carnitine (ALCAR) 2g
Number of subjects: 60
Study 24321164 — intervention group
Group type: EXPERIMENTAL
Intervention: Modafinil 200mg
Number of subjects: 60
Study 24321164 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 20464812 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise in 25 degrees C water
Number of subjects: 8
Study 20464812 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise in 38.5 degrees C water
Number of subjects: 8
Study 20464812 — intervention group
Group type: EXPERIMENTAL
Intervention: Change in core temperature (T(re)) during exercise
Number of subjects: 8
Study 20464812 — intervention group
Group type: EXPERIMENTAL
Intervention: Change in cortisol
Number of subjects: 8
Study 20464812 — intervention group
Group type: EXPERIMENTAL
Intervention: Change in TNF-alpha
Number of subjects: 8
Study 18538054 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 mL 0.25% levobupivacaine
Number of subjects: 50
Study 18538054 — intervention group
Group type: COMPARATOR
Intervention: 60 mL saline placebo (control group)
Number of subjects: 50
Study 15855886 — intervention group
Group type: EXPERIMENTAL
Intervention: Somatosensory and motor evoked potentials (SEP and MEP) examination
Number of subjects: 0
Study 15855886 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial magnetic stimulation for measuring central and peripheral conduction time (CCT and PCT)
Number of subjects: 0
Study 15855886 — intervention group
Group type: COMPARATOR
Intervention: Control group of volunteers
Number of subjects: 0
Study 11823754 — intervention group
Group type: EXPERIMENTAL
Intervention: Grapefruit juice (250 ml)
Number of subjects: 24
Study 10508948 — intervention group
Group type: EXPERIMENTAL
Intervention: Subaxillary extrapleural approach
Number of subjects: 836
Study 10508948 — intervention group
Group type: COMPARATOR
Intervention: Routine surgical technique (posterolateral approach)
Number of subjects: 836
Study 7717487 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiopentone (step 1: 1.25 mg.kg‐1 followed by 2.5 mg.kg‐1.h‐1; step 2: 1.25 mg.kg‐1 and 12.5 mg.kg‐1.h‐1; n = 15)
Number of subjects: 30
Study 7717487 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol (step 1: 0.5 mg.kg‐1, 1 mg.kg‐1.h‐1; step 2: 0.5 mg.kg‐1, 5 mg.kg‐1.h‐1; n = 15)
Number of subjects: 30
Study 1645643 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial ileal bypass surgery
Number of subjects: 838
Study 6791864 — intervention group
Group type: EXPERIMENTAL
Intervention: Penicillin (55 mg/kg/day for 7 days)
Number of subjects: 149
Study 6791864 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 149
Study 6791864 — intervention group
Group type: EXPERIMENTAL
Intervention: Penicillin
Number of subjects: 149
Study 6791864 — intervention group
Group type: COMPARATOR
Intervention: Penicillin and Placebo
Number of subjects: 149
Study 29605109 — intervention group
Group type: EXPERIMENTAL
Intervention: Video clip
Number of subjects: 74
Study 29605109 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone conversation with a radiographer
Number of subjects: 74
Study 29605109 — intervention group
Group type: COMPARATOR
Intervention: Routine appointment letter and information sheet
Number of subjects: 74
Study 27325327 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-centered education program
Number of subjects: 0
Study 27325327 — intervention group
Group type: COMPARATOR
Intervention: Didactic education program
Number of subjects: 0
Study 24635935 — intervention group
Group type: EXPERIMENTAL
Intervention: rTMS 1000 stimulations/day at 1 Hz and 110% of the motor threshold for 5 consecutive days
Number of subjects: 28
Study 24635935 — intervention group
Group type: EXPERIMENTAL
Intervention: rTMS 2000 stimulations/day at 1 Hz and 110% of the motor threshold for 5 consecutive days
Number of subjects: 28
Study 24635935 — intervention group
Group type: EXPERIMENTAL
Intervention: rTMS 1000 pulse
Number of subjects: 28
Study 24635935 — intervention group
Group type: EXPERIMENTAL
Intervention: rTMS 2000 pulse
Number of subjects: 28
Study 24635935 — intervention group
Group type: COMPARATOR
Intervention: Comparison between 1000 pulse and 2000 pulse treatment arms
Number of subjects: 28
Study 23754188 — intervention group
Group type: EXPERIMENTAL
Intervention: Rilonacept (2.2 mg/kg or 4.4 mg/kg)
Number of subjects: 24
Study 23754188 — intervention group
Group type: EXPERIMENTAL
Intervention: Rilonacept
Number of subjects: 24
Study 23754188 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 20804367 — intervention group
Group type: EXPERIMENTAL
Intervention: Methyl B12 (64.5 mcg/kg every three days for 6 weeks)
Number of subjects: 30
Study 20804367 — intervention group
Group type: COMPARATOR
Intervention: Placebo (6 weeks)
Number of subjects: 30
Study 20804367 — intervention group
Group type: EXPERIMENTAL
Intervention: Methyl B12 responders (30% of subjects)
Number of subjects: 30
Study 20804367 — intervention group
Group type: EXPERIMENTAL
Intervention: Methyl B12 responders
Number of subjects: 30
Study 18422809 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron supplementation (Fe-IR)
Number of subjects: 154
Study 18422809 — intervention group
Group type: COMPARATOR
Intervention: Iron supplementation (non-iron-replete infants)
Number of subjects: 154
Study 15882144 — intervention group
Group type: EXPERIMENTAL
Intervention: Ucn 1 infusion (50 microg intravenously over 1 hour)
Number of subjects: 8
Study 15882144 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 12933408 — intervention group
Group type: EXPERIMENTAL
Intervention: Droperidol 5 micro g
Number of subjects: 329
Study 12933408 — intervention group
Group type: EXPERIMENTAL
Intervention: Droperidol 15 micro g
Number of subjects: 329
Study 12933408 — intervention group
Group type: EXPERIMENTAL
Intervention: Droperidol 50 micro g
Number of subjects: 329
Study 12933408 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 329
Study 11682935 — intervention group
Group type: EXPERIMENTAL
Intervention: One duck introduced to ponds
Number of subjects: 9
Study 11682935 — intervention group
Group type: EXPERIMENTAL
Intervention: Two ducks introduced to ponds
Number of subjects: 9
Study 11682935 — intervention group
Group type: COMPARATOR
Intervention: Control (no ducks introduced)
Number of subjects: 9
Study 8823899 — intervention group
Group type: EXPERIMENTAL
Intervention: Ganzfeld perceptual field with 1 sec. interstimulus interval
Number of subjects: 143